• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$3.60 -$0.03 (-0.83%)

REAL-TIME: Last trade at

Harvard Bioscience, Inc.

NASDAQ:HBIO

Jump to this page for:

Related Resources

Harvard Bioscience backs 2012 non-GAAP EPS view of 39c-42c for LSRT unit

5/3/2012 by Theflyonthewall.com

Harvard Bioscience sees Q2 revenue $28M-$29M

5/3/2012 by Theflyonthewall.com

Harvard Bioscience, Inc. (HBIO) Reports Q1 EPS of $0.09; Guides Q2

5/3/2012 by StreetInsider.com

Harvard Bioscience reports Q1 EPS 6c vs. 7c in Q1 of 2011

5/3/2012 by Theflyonthewall.com

Harvard Bioscience, Inc. Schedules First Quarter 2012 Conference Call for May 3, 2012

4/30/2012 by NASDAQ

Harvard Bioscience, Inc. Schedules First Quarter 2012 Conference Call for May 3, 2012

4/30/2012 by GlobeNewswire

Harvard Bioscience tracheal transplant recipient dies

3/6/2012 by Theflyonthewall.com

Harvard Bioscience Comments on the Passing of Christopher Lyles

3/6/2012 by GlobeNewswire

Harvard Bioscience sees 2012 LSRT adjusted EPS 39c-42c, up 11%-20% yoy

3/1/2012 by Theflyonthewall.com

Harvard Bioscience sees Q1 LSRT adjusted EPS 8c-9c

3/1/2012 by Theflyonthewall.com

Harvard Bioscience reports Q4 EPS 2c vs. 8c in Q4 of 2010

3/1/2012 by Theflyonthewall.com

Harvard Bioscience, Inc. (HBIO) Reports Q4 Earnings of $0.07; Guides FY12, Q1 EPS

3/1/2012 by StreetInsider.com

HBIO Reports Fourth Quarter 2011 Results

3/1/2012 by GlobeNewswire

Harvard Bioscience, Inc. Schedules Fourth Quarter 2011 Conference Call for March 1, 2012

2/27/2012 by GlobeNewswire

Harvard Bioscience (HBIO) Acquires AHN Biotechnologie GmbH

2/8/2012 by StreetInsider.com

Harvard Bioscience, Inc. Acquires AHN

2/7/2012 by StockWatch

Harvard Bioscience acquires business of AHN Biotechnologie through subsidiary

2/7/2012 by Theflyonthewall.com

Harvard Bioscience, Inc. Acquires AHN

2/7/2012 by GlobeNewswire

Harvard Bioscience, Inc. Announces Participation in the Regenerative Medicine Insight Track at the Biotech Showcase

1/9/2012 by StockWatch

Harvard Bioscience, Inc. Announces Participation in the Regenerative Medicine Insight Track at the Biotech Showcase

1/9/2012 by GlobeNewswire

Harvard Bioscience's "InBreath" Bioreactor Used in World's Second Successful Synthetic Trachea Transplant

11/29/2011 by GlobeNewswire

Harvard Bioscience's InBreath Bioreactor Highlighted in Article in The Lancet Summarizing the World's First Synthetic Trachea Transplant

11/28/2011 by StockWatch

Harvard Bioscience's InBreath Bioreactor Highlighted in Article in The Lancet Summarizing the World's First Synthetic Trachea Transplant

11/28/2011 by GlobeNewswire

Harvard Bioscience initiated with a Buy at Sidoti

11/21/2011 by Theflyonthewall.com

HBIO Reports Third Quarter 2011 Results

11/3/2011 by GlobeNewswire

Harvard Bioscience, Inc. Schedules Third Quarter 2011 Conference Call for November 3, 2011

10/28/2011 by StockWatch

Harvard Bioscience, Inc. Schedules Third Quarter 2011 Conference Call for November 3, 2011

10/28/2011 by GlobeNewswire

Insider Buying Alert: 9 Stocks That Everyone Thinks Will Soar Higher

10/28/2011 by The Motley Fool

Harvard Bioscience (HBIO) May Have Begun Sale Process -DealReporter

10/20/2011 by StreetInsider.com

Harvard Bioscience strength attributed to report of possible sale

10/20/2011 by Theflyonthewall.com

HBIO President David Green to Present at the UBS 2011 Global Life Sciences Conference

9/12/2011 by GlobeNewswire

Harvard Bioscience management to meet with Benchmark Co.

8/12/2011 by Theflyonthewall.com

Evergreen, Chase Corp. lead Boston stock rebound

8/9/2011 by Boston Business Journal - Boston MA

Harvard Bioscience Inc. Reports Operating Results (10-Q)

8/9/2011 by GuruFocus

Harvard Bioscience, Inc. (HBIO) Reports Q2 Earnings of $0.08

8/4/2011 by StreetInsider.com

HBIO Reports Second Quarter 2011 Revenue Growth of 5% Over Second Quarter 2010

8/4/2011 by GlobeNewswire

Here's How Harvard Bioscience May Be Failing You

8/1/2011 by The Motley Fool

Harvard Bioscience, Inc. Schedules Second Quarter 2011 Conference Call for August 4, 2011

7/28/2011 by GlobeNewswire

Photo Release -- Harvard Bioscience's Bioreactor Grows a Synthetic Tissue-Engineered Trachea Used in World's First Successful Human Transplantation

7/7/2011 by StockWatch

Photo Release -- Harvard Bioscience's Bioreactor Grows a Synthetic Tissue-Engineered Trachea Used in World's First Successful Human Transplantation

7/7/2011 by GlobeNewswire
See More Articles...